Cargando…

The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert

Couple of ethnopharmacological surveys in the Indian Ladakh and Pakistani Shigar valleys has reported the medicinal use of Acantholimon lycopodioides against cardiac and gastric disorders that however, remains without scientific rationale or experimental validations. Here, we assess the in vitro bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvez, Mohammad K., Basudan, Omar A., Noman, Omar M., Al-Dosari, Mohammed S., Alqasoumi, Saleh I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499106/
https://www.ncbi.nlm.nih.gov/pubmed/32994707
http://dx.doi.org/10.1016/j.sjbs.2020.04.006
_version_ 1783583648760463360
author Parvez, Mohammad K.
Basudan, Omar A.
Noman, Omar M.
Al-Dosari, Mohammed S.
Alqasoumi, Saleh I.
author_facet Parvez, Mohammad K.
Basudan, Omar A.
Noman, Omar M.
Al-Dosari, Mohammed S.
Alqasoumi, Saleh I.
author_sort Parvez, Mohammad K.
collection PubMed
description Couple of ethnopharmacological surveys in the Indian Ladakh and Pakistani Shigar valleys has reported the medicinal use of Acantholimon lycopodioides against cardiac and gastric disorders that however, remains without scientific rationale or experimental validations. Here, we assess the in vitro bio/therapeutic activities of A. lycopodioides extracts as well as chloroform, ethyl acetate, n-butanol and aqueous fractions. The in vitro β-carotene-linoleic acid bleaching and DPPH radical scavenging methods demonstrated a very high anti-oxidative property of chloroform and ethyl acetate fractions compared to others. Cell viability assay (MTT) on human cervical (HeLa), breast (MDA-MB321) and liver (HepG2) cancer cells revealed their differential cytotoxicity, except the chloroform fraction. Of these, the precipitate exerted highest cytotoxicity on HepG2 cells followed by aqueous fraction on MDA-MB321 cells. Notably, the non-cytotoxicity of chloroform fraction coincided with its highest anti-oxidative activity. Further, the chloroform fraction showed marked hepatoprotection (up to 84%) against 3′7′dichlorofluorescin triggered free radicals induced oxidative damage. Also, the hepatoprotective chloroform fraction mildly activated CYP3A4 in HepG2 cells (dual-luciferase assay). Moreover, the A. lycopodioides extracts and fractions showed differential anti-bacterial and anti-fungal activities. Of these, while S. aureus was more sensitive to the water-insoluble extract, ethyl acetate fraction showed moderate activity against E. coli and C. albicans. On the other hand, the chloroform fraction showed promising activity against S. Aureus, C. albicans, P. vulgaris and E. faecalis. In conclusion, our data for the first time, demonstrated promising anti-oxidative, hepatoprotective, anti-cancer, anti-microbial and CYP3A4 activating salutations of A. lycopodioides. This warrants further studies towards isolation and identification of its therapeutically active principles.
format Online
Article
Text
id pubmed-7499106
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74991062020-09-28 The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert Parvez, Mohammad K. Basudan, Omar A. Noman, Omar M. Al-Dosari, Mohammed S. Alqasoumi, Saleh I. Saudi J Biol Sci Original Article Couple of ethnopharmacological surveys in the Indian Ladakh and Pakistani Shigar valleys has reported the medicinal use of Acantholimon lycopodioides against cardiac and gastric disorders that however, remains without scientific rationale or experimental validations. Here, we assess the in vitro bio/therapeutic activities of A. lycopodioides extracts as well as chloroform, ethyl acetate, n-butanol and aqueous fractions. The in vitro β-carotene-linoleic acid bleaching and DPPH radical scavenging methods demonstrated a very high anti-oxidative property of chloroform and ethyl acetate fractions compared to others. Cell viability assay (MTT) on human cervical (HeLa), breast (MDA-MB321) and liver (HepG2) cancer cells revealed their differential cytotoxicity, except the chloroform fraction. Of these, the precipitate exerted highest cytotoxicity on HepG2 cells followed by aqueous fraction on MDA-MB321 cells. Notably, the non-cytotoxicity of chloroform fraction coincided with its highest anti-oxidative activity. Further, the chloroform fraction showed marked hepatoprotection (up to 84%) against 3′7′dichlorofluorescin triggered free radicals induced oxidative damage. Also, the hepatoprotective chloroform fraction mildly activated CYP3A4 in HepG2 cells (dual-luciferase assay). Moreover, the A. lycopodioides extracts and fractions showed differential anti-bacterial and anti-fungal activities. Of these, while S. aureus was more sensitive to the water-insoluble extract, ethyl acetate fraction showed moderate activity against E. coli and C. albicans. On the other hand, the chloroform fraction showed promising activity against S. Aureus, C. albicans, P. vulgaris and E. faecalis. In conclusion, our data for the first time, demonstrated promising anti-oxidative, hepatoprotective, anti-cancer, anti-microbial and CYP3A4 activating salutations of A. lycopodioides. This warrants further studies towards isolation and identification of its therapeutically active principles. Elsevier 2020-10 2020-04-14 /pmc/articles/PMC7499106/ /pubmed/32994707 http://dx.doi.org/10.1016/j.sjbs.2020.04.006 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Parvez, Mohammad K.
Basudan, Omar A.
Noman, Omar M.
Al-Dosari, Mohammed S.
Alqasoumi, Saleh I.
The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert
title The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert
title_full The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert
title_fullStr The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert
title_full_unstemmed The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert
title_short The first bioactivity studies of Acantholimon lycopodioides from high altitude Karakoram-Himalayan desert
title_sort first bioactivity studies of acantholimon lycopodioides from high altitude karakoram-himalayan desert
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499106/
https://www.ncbi.nlm.nih.gov/pubmed/32994707
http://dx.doi.org/10.1016/j.sjbs.2020.04.006
work_keys_str_mv AT parvezmohammadk thefirstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT basudanomara thefirstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT nomanomarm thefirstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT aldosarimohammeds thefirstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT alqasoumisalehi thefirstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT parvezmohammadk firstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT basudanomara firstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT nomanomarm firstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT aldosarimohammeds firstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert
AT alqasoumisalehi firstbioactivitystudiesofacantholimonlycopodioidesfromhighaltitudekarakoramhimalayandesert